Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications.
Blood
Cannabis
Impaired driving
Marijuana
Oral fluid
THC
Journal
Accident; analysis and prevention
ISSN: 1879-2057
Titre abrégé: Accid Anal Prev
Pays: England
ID NLM: 1254476
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
29
12
2021
revised:
25
03
2022
accepted:
03
05
2022
pubmed:
1
6
2022
medline:
15
6
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Cannabis is the second most commonly used impairing substance by drivers, after alcohol. As more countries legalize cannabis, there is concern that cannabis-impaired driving will increase. In many countries, police use roadside devices to test for oral fluid THC (the primary psychotropic component in cannabis) to identify drivers who used cannabis; including in countries with non-zero per se limits for THC in blood. This practice is questioned as previous research demonstrates a poor correlation between oral fluid and blood THC concentrations at the individual level. We conducted a meta-analysis to identify all research that compared oral fluid with blood THC levels. We obtained individual-level data from study authors and analyzed pooled individual-level data to calculate sensitivity and specificity of oral fluid THC (at various cut-off values) to detect blood THC above different concentration limits. Finally, we explored practical implications of using oral fluid THC in an enforcement context. Our review found THC concentrations measured in over 18,000 paired samples of oral fluid and blood. We found a good correlation between the presence of THC in oral fluid and presence of THC in blood (sensitivity = 71.2%, specificity = 97.7%). However oral fluid THC, at commonly used cut-off values, is less sensitive and less specific when used as a biomarker to detect people with blood THC concentrations above commonly used per se limits (such as 5 ng/mL). As such, there will be a large number of "false positive" tests if oral fluid THC testing were used as a biomarker for "illegal" THC concentrations in randomly selected drivers. We argue that the adverse implications of false positive oral fluid THC tests in this context outweigh the possible road safety benefits and we recommend against oral fluid THC screening in randomly selected drivers in countries with non-zero per se limits for blood THC. In contrast, oral fluid THC tests appear to be useful for investigating "high-risk" drivers who come to police attention because of evidence of impairment.
Identifiants
pubmed: 35640367
pii: S0001-4575(22)00130-0
doi: 10.1016/j.aap.2022.106694
pii:
doi:
Substances chimiques
Biomarkers
0
Dronabinol
7J8897W37S
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
106694Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.